Completed OBSERVATIONAL NCT01415115

Using SCOUT Noninvasive AGE Measurements to Forecast Diabetes Complications (MARC)

A Cross-Sectional Study to Test the Feasibility of Using SCOUT Noninvasive AGE Measurements to Forecast Diabetes Complications

Sponsor: Medstar Health Research Institute

Conditions Type 1 Diabetes Type 2 Diabetes

Updated 11 times since 2017 Last updated: Aug 10, 2011 Started: Mar 31, 2007 Primary completion: Aug 31, 2011 Completion: Aug 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Type 1 Diabetes and Type 2 Diabetes and is currently completed. Medstar Health Research Institute leads this study, which shows 11 recorded versions since 2007 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 6 earlier versions

Jun 2018 — Nov 2020 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Completed NA
Feb 2017 — Aug 2017 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Mar 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medstar Health Research Institute
VeraLight, Inc.

Data source: VeraLight, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hyattsville, United States